Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Preferred Shares: 2016

Historic Preferred Shares for UroGen Pharma (URGN) over the last 1 years, with Dec 2016 value amounting to $13,000.

  • UroGen Pharma's Preferred Shares fell 100.66% to -$3,780 in Q3 2017 from the same period last year, while for Sep 2017 it was -$3,780, marking a year-over-year decrease of 100.66%. This contributed to the annual value of $13,000 for FY2016, which is N/A change from last year.
  • According to the latest figures from FY2016, UroGen Pharma's Preferred Shares is $13,000.
  • UroGen Pharma's 5-year Preferred Shares high stood at $13,000 for FY2016, and its period low was $13,000 during FY2016.
  • Over the past 1 years, UroGen Pharma's median Preferred Shares value was $13,000 (recorded in 2016), while the average stood at $13,000.